Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

LifeStance Health (LFST) EPS (Weighted Average and Diluted): 2021-2024

Historic EPS (Weighted Average and Diluted) for LifeStance Health (LFST) over the last 4 years, with FY2024 value amounting to -$0.15.

  • LifeStance Health's EPS (Weighted Average and Diluted) rose 8333.33% to -$0.01 in Q2 2025 from the same period last year, while for Sep 2025 it was -$0.23, marking a year-over-year decrease of 105000.0%. This contributed to the annual value of -$0.15 for FY2024, which is 7058.82% up from last year.
  • According to the latest figures from FY2024, LifeStance Health's EPS (Weighted Average and Diluted) is -$0.15, which was up 7058.82% from -$0.51 recorded in FY2023.
  • LifeStance Health's EPS (Weighted Average and Diluted)'s 5-year high stood at -$0.15 during FY2024, with a 5-year trough of -$1.05 in FY2021.
  • For the 4-year period, LifeStance Health's EPS (Weighted Average and Diluted) averaged around -$0.58, with its median value being -$0.56 (2022).
  • In the last 5 years, LifeStance Health's EPS (Weighted Average and Diluted) surged by 1639.34% in 2023 and then soared by 7058.82% in 2024.
  • Over the past 4 years, LifeStance Health's EPS (Weighted Average and Diluted) (Annual) stood at -$1.05 in 2021, then soared by 41.9% to -$0.61 in 2022, then grew by 16.39% to -$0.51 in 2023, then soared by 70.59% to -$0.15 in 2024.
  • Its EPS (Weighted Average and Diluted) was -$0.15 in FY2024, compared to -$0.51 in FY2023 and -$0.61 in FY2022.